Use of Traditional Medicines to Fight COVID-19 during the South African Nationwide Lockdown: A Prevalence Study among University Students and Academic Staff

Author:

Mphekgwana Peter M.,Makgahlela Mpsanyana,Mothiba Tebogo M.

Abstract

Introduction: The coronavirus (COVID-19) pandemic has caused major public respiratory illness worldwide. To date, no specific treatment for COVID-19 has proven effective, thus leading people to rely on diverse measures including the use of traditional medicines. Aim: The study aimed at determining the prevalence of traditional medicine use amongst university staff and students, and to examine the association of traditional medicine use with mental status and health parameters. Methods: A quantitative descriptive cross-sectional design research method was used in this study. The targeted population was the university staff members and students in one rural-based university. Results: A total of 400 individuals in rural-based university responded to the online survey; approximately more than three quarters were students 313 (78.3%) and single (86%). The ages of participants ranged from 17 to 66 years, with a median age of 22 years. The prevalence of the use of traditional medicines to respond to COVID-19 was 30.4%. A significantly higher proportion of use of traditional medicines was by participants with mental health impacts (62% vs. 37%), those who postponed medical appointments (48% vs. 22%) and those who failed to buy prescribed medications (36% vs. 14%). Conclusion: A considerable proportion of university staff members and students were found to be using traditional medicines in responding to COVID-19 during the South African nationwide lockdown. Policymakers and researchers are recommended to look more into the health benefits of traditional medicines, including clinical trials, to establish medicinal safety and efficacy.

Publisher

Bentham Science Publishers Ltd.

Subject

Public Health, Environmental and Occupational Health,Community and Home Care,Health (social science)

Reference22 articles.

1. Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care 2020; 24 (1) : 198.

2. Silveira D, Prieto-Garcia JM, Boylan F, et al. COVID-19: Is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Front Pharmacol 2020; 11 : 581840.

3. Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med 2020; 1-8.

4. Naming the coronavirus disease (COVID-19) and the virus that causes it. WHO 2020. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

5. Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: A review of their mechanisms, pros and cons. Evid Based Complement Alternat Med 2020; 2020 : 2560645.

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3